製品の概要

  • 製品名Anti-C9 antibody [aE11]
    C9 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [aE11] to C9
  • アプリケーション適用あり: ELISA, IHC-P, IHC-Fr, Flow Cyt, Functional Studiesmore details
    適用なし: WB
  • 種交差性
    交差種: Horse, Human, Pig
  • 免疫原

    Human purified MAC (membrane attack complex)

  • ポジティブ・コントロール
    • Mucosa from patients with H. Pylori.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • バッファーPreservative: 0.02% Sodium Azide
    Constituents: 0.1% BSA, PBS
  • Concentration information loading...
  • 精製度Protein A purified
  • 特記事項(精製)ab90801 was filtered through a 0.2 µm filter.
  • ポリ/モノモノクローナル
  • クローン名aE11
  • アイソタイプIgG2a
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab90801 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ELISA Use at an assay dependent concentration.
IHC-P 1/50.
IHC-Fr 1/50.
Flow Cyt 1/50. ab170191-Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.
Functional Studies Use at an assay dependent concentration. aE11 inhibits platelet activation by antiphospholipid antibody serum.
  • 追加情報Is unsuitable for WB.
  • ターゲット情報

    • 機能Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C9 is the pore-forming subunit of the MAC.
    • 組織特異性Plasma.
    • 関連疾患Defects in C9 are a cause of complement component 9 deficiency (C9D) [MIM:613825]. A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis.
    • 配列類似性Belongs to the complement C6/C7/C8/C9 family.
      Contains 1 EGF-like domain.
      Contains 1 LDL-receptor class A domain.
      Contains 1 MACPF domain.
      Contains 1 TSP type-1 domain.
    • 翻訳後修飾Thrombin cleaves factor C9 to produce C9a and C9b.
      Phosphorylation sites are present in the extracelllular medium.
    • 細胞内局在Secreted. Cell membrane. Secreted as soluble monomer. Oligomerizes at target membranes, forming a pre-pore. A conformation change then leads to the formation of a 100 Angstrom diameter pore.
    • Information by UniProt
    • 参照データベース
    • 別名
      • C9 antibody
      • C9 deficiency antibody
      • C9 deficiency with dermatomyositis antibody
      • CO9_HUMAN antibody
      • Complement component 9 antibody
      • Complement component 9 deficiency antibody
      • Complement component C9 antibody
      • Complement component C9b antibody
      see all

    Anti-C9 antibody [aE11] (ab90801) 使用論文

    This product has been referenced in:
    • Meuwissen M  et al. Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction. J Clin Pathol 59:196-201 (2006). IHC-Fr ; Human . Read more (PubMed: 16443738) »
    • Berstad AE  et al. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut 40:196-203 (1997). IHC-P, IF ; Human . Read more (PubMed: 9071931) »

    See all 5 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab90801.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"